SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-014261
Filing Date
2022-04-13
Accepted
2022-04-13 09:21:08
Documents
15
Period of Report
2022-04-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ny20002681x1_8k.htm   iXBRL 8-K 59685
2 EXHIBIT 2.1 ny20002681x1_ex2-1.htm EX-2.1 497217
3 EXHIBIT 3.1 ny20002681x1_ex3-1.htm EX-3.1 5158
4 EXHIBIT 99.1 ny20002681x1_ex99-1.htm EX-99.1 35466
  Complete submission text file 0001140361-22-014261.txt   879659

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA atrs-20220412.xsd EX-101.SCH 3938
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE atrs-20220412_lab.xml EX-101.LAB 23289
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atrs-20220412_pre.xml EX-101.PRE 16560
9 EXTRACTED XBRL INSTANCE DOCUMENT ny20002681x1_8k_htm.xml XML 4383
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 22823819
SIC: 3841 Surgical & Medical Instruments & Apparatus